Are my patients with rheumatic diseases at higher risk of COVID-19?

Figueroa-Parra, Gabriel; Aguirre-Garcia, Gloria Mayela; Gamboa-Alonso, Carmen Magdalena; Camacho-Ortiz, Adrian; Galarza-Delgado, Dionicio Angel

Figueroa-Parra, Gabriel; Aguirre-Garcia, Gloria Mayela; Gamboa-Alonso, Carmen Magdalena; Camacho-Ortiz, Adrian; Galarza-Delgado, Dionicio Angel.

Figueroa-Parra G; Servicio de Reumatología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Aguirre-Garcia GM; Servicio de Infectología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Gamboa-Alonso CM; Servicio de Reumatología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Camacho-Ortiz A; Servicio de Infectología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Galarza-Delgado DA; Servicio de Reumatología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico dgalarza@medicinauanl.mx.

Ann Rheum Dis ; 79(6): 839-840, 2020 06.

Article in English | MEDLINE | ID: covidwho-13923

Subject(s)

Antirheumatic Agents; Arthritis, Rheumatoid; Rheumatic Diseases; Adult; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vaccination

Keywords

DMARDs (biologic); DMARDs (synthetic); autoimmune diseases; epidemiology; infections

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatic Diseases / Antirheumatic Agents Type of study: Prognostic study Topics: Vaccines Limits: Adult / Humans Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217322

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google